Trial
NCT02297490
Evaluation of the Utility of an EEC for Assessing Efficacy of SIT in Pivotal Clinical Trials
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Allergopharma GmbH & Co. KG
Collaborators
Inflamax Research Incorporated
Condition
Allergic Rhinoconjunctivitis
Intervention
Placebo
Why stopped
The study was terminated due to the interim Analysis results indicating a weaker correlation than anticipated and reported by other study groups.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-17